Research Article

Obesity and Prognostic Variables in Colombian Breast Cancer Patients: A Cross-Sectional Study

Table 1

Patient demographic and tumor histopathologic characteristics.

Characteristics

Mean age at time of diagnosis in years (range)54 (26–91)

Age groups, years, (%)
 <35 years41 (4.83)
 35–3941 (4.83)
 40–49245 (28.86)
 50–59223 (26.27)
 60–69172 (20.26)
 ≥70127 (14.96)

Menopausal status, (%) (%)
 Premenopausal496 (58.42)
 Postmenopausal353 (41.58)

BMI, mean (range), (%)27.4 (14–49.9)
 Unknown15 (1.7%)
 <18.513 (1.53%)
 18.5–24.9291 (34.28%)
 25–29291 (34.28%)
 ≥30239 (28.15%)

Tumor size, (%) (%)
 TX25 (2.94)
 T1210 (24.73)
 T2301 (35.45)
 T3140 (16.49)
 T4173 (20.38)

Lymph node status, (%)
 Nx293 (34.51)
 N0304 (35.8)
 N1–N3252 (29.68)

TNM, (%)
 I176 (20.73)
 II389 (45.82)
 III228 (26.86)
 IV32 (3.77)

Histological subtype, (%)
 Ductal invasive711 (83.7)
 Lobular invasive57 (6.71)
 Other37 (4.36)

Tumor grade, (%)
 G1143 (16.84)
 G2375 (44.17)
 G3211 (24.85)

Estrogen receptor status, (%)
 Positive605 (71.26)
 Negative244 (28.74)

Progesterone receptor status, (%)
 Positive537 (63.25)
 Negative312 (36.75)

HER 2, (%)
 Positive211 (24.85)
 Negative601 (70.79)
 Unknown37 (4.36)

Tumor subtype (IHC4), (%)
 Luminal A298 (35.1)
 Luminal B, HER 2−172 (20.26)
 Luminal B, HER 2+131 (15.43)
 Her 2-enriched79 (9.31)
 Triple negative133 (15.67)